US Food and Drug Administration to set up new oncology office

被引：0
|
作者：
Tilstone, C
机构：
来源：
LANCET ONCOLOGY | 2004年 / 5卷 / 09期
关键词：
D O I：
10.1016/S1470-2045(04)01549-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：518 / 518
页数：1
相关论文
共 50 条
  • [21] Independence at the US Food and Drug Administration
    不详
    LANCET, 2006, 367 (9523): : 1630 - 1630
  • [22] Transparency at the US Food and Drug Administration
    Califf, Robert M.
    JOURNAL OF LAW MEDICINE & ETHICS, 2017, 45 : 24 - 28
  • [23] US Food and Drug Administration Office of Women's Health: Promoting Therapeutic Optimization in Women
    South, Erin M.
    Zinn, Rebekah L.
    Huang, Caroline J.
    Vasisht, Kaveeta P.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 60 : S11 - S17
  • [24] The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine
    Zhang, Jing
    Mathis, Mitchell V.
    Sellers, Jenn W.
    Kordzakhia, George
    Jackson, Andre J.
    Dow, Antonia
    Yang, Peiling
    Fossom, Linda
    Zhu, Hao
    Patel, Hiren
    Unger, Ellis F.
    Temple, Robert J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (01) : 8 - 14
  • [25] The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin
    Mathis, Mitchell V.
    Muoio, Brendan M.
    Andreason, Paul
    Avila, Amy M.
    Farchione, Tiffany
    Atrakchi, Aisar
    Temple, Robert J.
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (06) : E668 - E673
  • [26] Integrated Drug Reviews at the US Food and Drug Administration
    Woodcock, Janet
    Stein, Peter
    Bugin, Kevin
    JAMA INTERNAL MEDICINE, 2020, 180 (09) : 1248 - 1250
  • [27] Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Study
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 (07) : 407 - 408
  • [28] US Food and Drug Administration: Initial Experience with the Real-Time Oncology Review Program
    de Claro, R. Angelo
    Gao, Jennifer J.
    Kim, Tamy
    Kluetz, Paul G.
    Theoret, Marc R.
    Beaver, Julia A.
    Pazdur, Richard
    CLINICAL CANCER RESEARCH, 2021, 27 (01) : 11 - 14
  • [29] Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
    Tsimberidou, Apostolia-Maria
    Braiteh, Fadi
    Stewart, David J.
    Kurzrock, Razelle
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (36) : 6243 - 6250
  • [30] Regulatory review intervals for ophthalmic new drug applications at the US food and drug administration
    Novack, GD
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1998, 126 (01) : 122 - 126
12345